Disulfiram, a Re-positioned Aldehyde Dehydrogenase Inhibitor, Enhances Radiosensitivity of Human Glioblastoma Cells In Vitro

PURPOSE: Glioblastoma, the most common brain tumor in adults, has poor prognosis. The purpose of this study was to determine the effect of disulfiram (DSF), an aldehyde dehydrogenase inhibitor, on in vitro radiosensitivity of glioblastoma cells with different methylation status of O(6)-methylguanine...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Cancer Res Treat
Hlavní autoři: Koh, Hyeon Kang, Seo, Soo Yeon, Kim, Jin Ho, Kim, Hak Jae, Chie, Eui Kyu, Kim, Seung-Ki, Kim, Il Han
Médium: Artigo
Jazyk:Inglês
Vydáno: Korean Cancer Association 2019
Témata:
Original Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6473295/
https://ncbi.nlm.nih.gov/pubmed/30121967
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2018.249
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky